Literature DB >> 28982736

An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung.

Kelli L Hvorecny1, Emily Dolben2, Sophie Moreau-Marquis2, Thomas H Hampton2, Tamer B Shabaneh2, Becca A Flitter3, Christopher D Bahl1, Jennifer M Bomberger3, Bruce D Levy4, Bruce A Stanton2, Deborah A Hogan2, Dean R Madden1.   

Abstract

The opportunistic pathogen Pseudomonas aeruginosa colonizes the lungs of susceptible individuals by deploying virulence factors targeting host defenses. The secreted factor Cif (cystic fibrosis transmembrane conductance regulator inhibitory factor) dysregulates the endocytic recycling of CFTR and thus reduces CFTR abundance in host epithelial membranes. We have postulated that the decrease in ion secretion mediated by Cif would slow mucociliary transport and decrease bacterial clearance from the lungs. To test this hypothesis, we explored the effects of Cif in cultured epithelia and in the lungs of mice. We developed a strategy to interpret the "hurricane-like" motions observed in reconstituted cultures and identified a Cif-mediated decrease in the velocity of mucus transport in vitro. Presence of Cif also increased the number of bacteria recovered at two time points in an acute mouse model of pneumonia caused by P. aeruginosa. Furthermore, recent work has demonstrated an inverse correlation between the airway concentrations of Cif and 15-epi-lipoxin A4, a proresolving lipid mediator important in host defense and the resolution of pathogen-initiated inflammation. Here, we observe elevated levels of 15-epi-lipoxin A4 in the lungs of mice infected with a strain of P. aeruginosa that expresses only an inactive form of cif compared with those mice infected with wild-type P. aeruginosa. Together these data support the inclusion of Cif on the list of virulence factors that assist P. aeruginosa in colonizing and damaging the airways of compromised patients. Furthermore, this study establishes techniques that enable our groups to explore the underlying mechanisms of Cif effects during respiratory infection.

Entities:  

Keywords:  airway clearance; gram-negative bacteria; host-pathogen interactions; mucociliary transport; opportunistic pathogens; pro-resolution mediators; α/β-hydrolase

Mesh:

Substances:

Year:  2017        PMID: 28982736      PMCID: PMC5866430          DOI: 10.1152/ajplung.00383.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  27 in total

Review 1.  British Thoracic Society guideline for non-CF bronchiectasis.

Authors:  M C Pasteur; D Bilton; A T Hill
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

2.  Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis.

Authors:  M W Tan; S Mahajan-Miklos; F M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung.

Authors:  Alex H Gifford; Sven D Willger; Emily L Dolben; Lisa A Moulton; Dana B Dorman; Heather Bean; Jane E Hill; Thomas H Hampton; Alix Ashare; Deborah A Hogan
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

4.  Active-Site Flexibility and Substrate Specificity in a Bacterial Virulence Factor: Crystallographic Snapshots of an Epoxide Hydrolase.

Authors:  Kelli L Hvorecny; Christopher D Bahl; Seiya Kitamura; Kin Sing Stephen Lee; Bruce D Hammock; Christophe Morisseau; Dean R Madden
Journal:  Structure       Date:  2017-04-06       Impact factor: 5.006

5.  Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.

Authors:  N Chiang; T Takano; C B Clish; N A Petasis; H H Tai; C N Serhan
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

6.  Redundant phenazine operons in Pseudomonas aeruginosa exhibit environment-dependent expression and differential roles in pathogenicity.

Authors:  David A Recinos; Matthew D Sekedat; Adriana Hernandez; Taylor Sitarik Cohen; Hassan Sakhtah; Alice S Prince; Alexa Price-Whelan; Lars E P Dietrich
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

7.  Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigs.

Authors:  Mark J Hoegger; Maged Awadalla; Eman Namati; Omar A Itani; Anthony J Fischer; Alexander J Tucker; Ryan J Adam; Geoffrey McLennan; Eric A Hoffman; David A Stoltz; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-28       Impact factor: 11.205

8.  A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system.

Authors:  Jennifer M Bomberger; Siying Ye; Daniel P Maceachran; Katja Koeppen; Roxanna L Barnaby; George A O'Toole; Bruce A Stanton
Journal:  PLoS Pathog       Date:  2011-03-24       Impact factor: 6.823

Review 9.  Bench-to-bedside review: Bacterial virulence and subversion of host defences.

Authors:  Steven A R Webb; Charlene M Kahler
Journal:  Crit Care       Date:  2008-11-10       Impact factor: 9.097

10.  Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.

Authors:  R E Abdulnour; H P Sham; D N Douda; R A Colas; J Dalli; Y Bai; X Ai; C N Serhan; B D Levy
Journal:  Mucosal Immunol       Date:  2015-12-09       Impact factor: 7.313

View more
  9 in total

1.  Differential requirements for processing and transport of short-chain versus long-chain O-acylcarnitines in Pseudomonas aeruginosa.

Authors:  Jamie A Meadows; Graham G Willsey; Matthew J Wargo
Journal:  Microbiology       Date:  2018-03-08       Impact factor: 2.777

2.  Reliably sourced airway mucus.

Authors:  Katherine Joyner; Gregg A Duncan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

3.  Selection of reference genes for quantitative PCR: identifying reference genes for airway epithelial cells exposed to Pseudomonas aeruginosa.

Authors:  Thomas H Hampton; Katja Koeppen; Laura Bashor; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-10       Impact factor: 5.464

Review 4.  Co-opting oxylipin signals in microbial disease.

Authors:  Mengyao Niu; Nancy P Keller
Journal:  Cell Microbiol       Date:  2019-06       Impact factor: 3.715

5.  Cyclodextrins reduce the ability of Pseudomonas aeruginosa outer-membrane vesicles to reduce CFTR Cl- secretion.

Authors:  Roxanna Barnaby; Katja Koeppen; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

6.  Nanobody-based binding assay for the discovery of potent inhibitors of CFTR inhibitory factor (Cif).

Authors:  Natalia Vasylieva; Seiya Kitamura; Jiexian Dong; Bogdan Barnych; Kelli L Hvorecny; Dean R Madden; Shirley J Gee; Dennis W Wolan; Christophe Morisseau; Bruce D Hammock
Journal:  Anal Chim Acta       Date:  2019-01-09       Impact factor: 6.558

Review 7.  Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development.

Authors:  Ailin Yang; Yanjun Wu; Ganggang Yu; Haoyan Wang
Journal:  Respir Res       Date:  2021-07-14

8.  Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles.

Authors:  Katja Koeppen; Roxanna Barnaby; Angelyca A Jackson; Scott A Gerber; Deborah A Hogan; Bruce A Stanton
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

Review 9.  Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS.

Authors:  Julie Nijmeh; Bruce D Levy
Journal:  Cell Biochem Biophys       Date:  2021-06-27       Impact factor: 2.194

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.